End Cash: The amount of cash held by the company for the given period.
NovoCure Limited (NVCR) had End Cash of $103.39M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$174.35M |
|
$-24.50M |
|
$42.16M |
|
$132.19M |
|
$214.74M |
|
$-40.39M |
|
$-0.56M |
|
$-40.95M |
|
$-40.95M |
|
$-24.50M |
|
$-24.50M |
|
$-24.50M |
|
$-24.50M |
|
$-40.39M |
|
$-39.92M |
|
111.47M |
|
111.47M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$646.73M |
|
$99.67M |
|
$157.59M |
|
$804.33M |
|
$223.23M |
|
$236.69M |
|
$240.63M |
|
$463.86M |
|
$340.47M |
|
$340.47M |
|
$340.47M |
|
112.49M |
|
| Cash Flow Statement Financials | |
$-49.03M |
|
$437.28M |
|
$-451.34M |
|
$166.09M |
|
|
End Cash |
$103.39M |
$-62.70M |
|
$104.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.90 |
|
-- |
|
-- |
|
0.41 |
|
0.70 |
|
75.82% |
|
-23.17% |
|
-23.17% |
|
-- |
|
-23.49% |
|
-14.05% |
|
$-75.68M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
1.03 |
|
1.18 |
|
76.45 |
|
-7.20% |
|
-7.20% |
|
-3.05% |
|
-4.24% |
|
$3.03 |
|
$-0.68 |
|
$-0.44 |
|